Merestinib Completed Phase 1 Trials for Mantle Cell Lymphoma (MCL) / Colorectal Cancers / Cancer, Advanced Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02745769A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents